logo

Crowdly

Browser

Add to Chrome

Course 10814

Looking for Course 10814 test answers and solutions? Browse our comprehensive collection of verified answers for Course 10814 at lms.gmu.ac.ae.

Get instant access to accurate answers and detailed explanations for your course questions. Our community-driven platform helps students succeed!

A 29-year-old woman

presents with severe cyclic pelvic pain, 

dysmenorrhea

,

and dyspareunia for the past 2 years. Pain worsens during

menstruation and partially improves afterward and the patient described her

pain as severe. She is not planning pregnancy for the next few years

and is seeking both pain relief and contraception. She

previously used ibuprofen during menses with only mild relief.

Physical examination and clinical history suggest 

endometriosis

. The

physician decides to start pharmacological management.

Past Medical History:

Cancer at the age of 20 years, Perforated gastric ulcer

1.    

What is the best treatment regimen for the treatment of

pain? (1 points)

View this question

Which hormonal therapy is the best to be prescribed (along

with the type of use) and which one should be avoided? (3 points)

View this question

If the patient does not respond to COCs, why are GnRH

agonists and Danazol considered second-line rather than first-line therapy? (3

points)

View this question

If the

patient's

endometriosis

is unresponsive to first-line therapies, a GnRH agonist

such as Nafarelin might be considered. Looking at the medicinal chemistry of

natural GnRH, what specific structural modification is made to create

Nafarelin, and how does this chemical change improve its therapeutic viability?

(4 marks)

View this question

Describe the pharmacological management of endometriosis

, including all

first-line and alternative treatment options. In your answer, discuss how the

choice of therapy is influenced by patient factors such as desire for

contraception, contraindications to estrogen, and comorbidities. (4 marks)

View this question

Q2f. 

The patient previously

discontinued a Combined Oral Contraceptive (COC) due to nausea and breakthrough

bleeding. The estrogenic component of most COCs is Ethinyl Estradiol (EE) or

Mestranol (shown below). Why are these synthetic estrogens used in oral

contraceptives instead of natural 17β-estradiol, and how do they differ

chemically from one another?  (2 marks)

     

Image failed to load

View this question

Q2g. 

If this patient, who

is non-compliant with daily oral medications, opted for an intramuscular (IM)

injection instead of an IUD, she might

receive Depo-Provera

(Medroxyprogesterone acetate) or Lunelle (Estradiol cypionate +

Medroxyprogesterone acetate)

. Chemically, how is estradiol modified to

allow for a prolonged duration of action (14 to 28 days) when given as an IM

injection?  (2 Marks)

View this question

Q2d. What are the serious warning signs

that

should be explained to any patient starting COCs?

(1 points)

View this question

Q2e. 

If this patient had unprotected intercourse and

presents 

within 120 hours

, what are the two appropriate emergency

contraception options?

(1 points)

View this question

A 32-year-old woman visits

the pharmacy seeking advice on contraception. She has 

two children

 and

wants 

long-term pregnancy prevention

 for at least 5 years. She

reports 

heavy menses with cramps and mild anemia

. Her medical

history reveals 

Wilson disease

. She is non-compliant with daily

medications and prefers a method that does not require daily attention. She

previously used a 

combined oral contraceptive (COC)

 but

stopped because of 

nausea and breakthrough bleeding

 when

she occasionally missed pills. (13 Marks)

Q2a. Which contraceptive method is most appropriate

 for

this patient based on her condition and preferences?

(1 points)

View this question

Want instant access to all verified answers on lms.gmu.ac.ae?

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Browser

Add to Chrome